IP Library Granted Patent US 11,331,520
Granted Patent B2
US 11,331,520 · App. 16/599,389 · Granted May 17, 2022

Systems and methods for producing and delivering ultrasonic therapies for wound treatment and healing

Inventors: Ross Loven (Mankato, MN); Jeff Sampson (Minneapolis, MN); Li Qin (North Mankato, MN); Ryan Glen Tetzloff (Minnetonka, MN); Douglas Duchon (Chanhassen, MN)
Assignee: SANUWAVE HEALTH, INC.
A61N7/00A61N2007/0017A61N2007/0073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,331,520
App. No.
16/599,389
Granted
May 17, 2022
Kind
B2
Abstract

One embodiment is directed to a non-contact, medical ultrasound therapy system for generating and controlling low frequency ultrasound. The ultrasound therapy system includes a treatment wand including an ultrasonic transducer, a generator unit, and a cable coupling the treatment wand to the generator unit. The generator unit generates electric power output to drive the ultrasonic transducer and includes a digital frequency generator, wherein the generator unit digitally controls energy output at resonance frequency of the ultrasonic transducer.

Claims (9)

1. A method for digitally generating and controlling a low frequency ultrasound used in a non-contact medical ultrasound therapy system, comprising:

performing a power on self-test to an ultrasonic therapy system that includes a treatment wand comprising an ultrasonic transducer and a generator comprising an ultrasonic driver;

performing a frequency sweep using a sine wave to determine a serial resonance frequency of the ultrasonic transducer by identifying a relative minimum impedance of the ultrasonic transducer;

adjusting a digital frequency generator output frequency based on voltage vs. current phase angle to maintain a frequency lockup in a phase-continuous manner at the serial resonance frequency for exclusively non-contact low-load conditions and no-load conditions, wherein the system is driven at a constant current which maintains constant output displacement;

and monitoring voltage and phase detection circuits of the ultrasound therapy system for phase difference, and

wherein both a first microprocessor and a second microprocessor are configured to individually suspend operation of the ultrasound therapy system in a fault condition, wherein the fault condition corresponds to one or more of:

a temperature of the generator,

a temperature of the treatment wand,

a temperature of the ultrasonic transducer, an output voltage of the ultrasonic transducer, or a communication failure between the first microprocessor and the second microprocessor.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2025
From: NH EXPANSION CREDIT FUND HOLDINGS LP
To: SANUWAVE HEALTH, INC.
Reel/Frame 072416/0904 →
SECURITY INTEREST Recorded Sep 26, 2025
From: SANUWAVE HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 072385/0048 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2020
From: CELULARITY INC.
To: SANUWAVE HEALTH, INC.
Reel/Frame 054299/0846 →
SECURITY INTEREST Recorded Aug 7, 2020
From: SANUWAVE HEALTH, INC.
To: NH EXPANSION CREDIT FUND HOLDINGS LP
Reel/Frame 053435/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2020
From: CELULARITY FUNCTIONAL REGENERATION, LLC
To: CELULARITY INC.
Reel/Frame 053243/0080 →
Continuity (3)
Continuation 14546808 · Nov 18, 2014
Provisional Application 61909086 · Nov 26, 2013
Related Publication 20200179725A1 · Jun 11, 2020